Bath & Body Works’ (BBWI) “Outperform” Rating Reiterated at Telsey Advisory Group

Telsey Advisory Group reiterated their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a research note released on Monday morning, Marketbeat Ratings reports. Telsey Advisory Group currently has a $42.00 price objective on the stock. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2025 earnings at $2.07 EPS, FY2025 earnings at $3.28 EPS, Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.59 EPS.

Other equities research analysts have also issued reports about the stock. UBS Group lowered their price target on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a report on Thursday, August 29th. Evercore ISI decreased their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. Barclays lowered shares of Bath & Body Works from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $31.00 to $28.00 in a report on Friday, November 8th. Wells Fargo & Company decreased their price objective on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating for the company in a report on Wednesday, November 6th. Finally, The Goldman Sachs Group decreased their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $41.88.

Bath & Body Works Trading Up 1.9 %

BBWI opened at $35.90 on Monday. The company has a fifty day simple moving average of $30.93 and a 200 day simple moving average of $35.65. The firm has a market cap of $7.87 billion, a price-to-earnings ratio of 8.76, a PEG ratio of 1.14 and a beta of 1.79. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, analysts forecast that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a $0.20 dividend. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.23%. Bath & Body Works’s dividend payout ratio is presently 19.51%.

Insider Activity at Bath & Body Works

In related news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 0.27% of the stock is currently owned by insiders.

Institutional Trading of Bath & Body Works

A number of institutional investors have recently made changes to their positions in the stock. Franklin Resources Inc. lifted its stake in shares of Bath & Body Works by 50.8% in the 3rd quarter. Franklin Resources Inc. now owns 265,221 shares of the company’s stock worth $8,230,000 after acquiring an additional 89,350 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in shares of Bath & Body Works in the 3rd quarter worth approximately $39,000. Bard Financial Services Inc. acquired a new stake in shares of Bath & Body Works in the 3rd quarter worth approximately $412,000. TD Private Client Wealth LLC lifted its stake in shares of Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after acquiring an additional 331 shares during the period. Finally, Nomura Asset Management Co. Ltd. lifted its stake in shares of Bath & Body Works by 30.6% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 137,610 shares of the company’s stock worth $4,393,000 after acquiring an additional 32,233 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.